Responses
Other responses
Jump to comment:
- Published on: 9 October 2006
- Published on: 4 April 2006
- Published on: 9 October 2006Parthonogenetically created stem cells: A middle ground to takeShow More
Dear Editor,
Unfortunately, scientists have used fetal tissue in research since at least the 1930s, now the secrets of the Dead-Baby Industry reveal that aborted fetuses being dissected alive, harvested and sold in pieces to fuel a vast research enterprise. There are social implications of its existence. We all need moral intensity these days. We all need to take it very seriously. Patel¡¦s paper is written to obvia...
Conflict of Interest:
None declared. - Published on: 4 April 2006The problem is destruction of a human organismShow More
Dear Editor,
P Patel’s article in “Research Ethics: A natural stem cell therapy? How novel findings and biotechnology clarify the ethics of stem cell research,” in the April issue of the Journal did not clarify as much as it could have.
Rather than exploring the “naturalness” of stem cell therapy, a better understanding would come with examining “destructive” and “non- destructive” stem cell therapy. Firs...
Conflict of Interest:
None declared.
Other content recommended for you
- Regenerative medicine for neurological diseases—will regenerative neurosurgery deliver?
- Regenerative medicine: stem cells and the science of monstrosity
- Islet and stem cell transplantation for treating diabetes
- What’s in a name? Embryos, entities, and ANTities in the stem cell debate
- Is a consensus possible on stem cell research? Moral and political obstacles
- Current Science of Regenerative Medicine with Stem Cells
- Ethical and legal aspects of stem cell practices in Turkey: where are we?
- Potentiality of embryonic stem cells: an ethical problem even with alternative stem cell sources
- Stem cell therapy for myocardial repair
- Current outlook of cardiac stem cell therapy towards a clinical application